18F-FDG PET在轻度认知障碍阶段阿尔茨海默病患者中的诊断模式与预后模式不重叠
研究纳入82例在基线诊断流程中接受18F-FDG PET并随访至临床转化为阿尔茨海默病痴呆的轻度认知障碍 due to AD(MCI-AD)患者,比较全组与年龄匹配健康对照以验证诊断模式,并分析代谢与转化时间的相关性以识别预后模式。诊断模式为典型后部代谢减低且与转化时间无关,预后模式为右侧颞中回、颞下回及梭状回代谢水平与转化时间相关。Kaplan-Meier分析显示预后模式代谢减低患者转化显著更早(9个月 vs 19个月)。
要点
- 诊断模式为后部典型代谢减低(BA 7、18、19、30、31、40),与转化时间无关。
- 预后模式为右侧颞中回、颞下回及梭状回(BA 20、21、38)代谢水平与转化时间相关。
- 预后模式代谢减低患者转化显著更早(9个月 vs 19个月,Log rank p<0.02)。
核心结论
- FDG PET可作为MCI-AD自然人群中的进展生物标志物;捕获转化速度的是颞中回和颞下回代谢而非后部AD典型诊断模式。
- 所揭示的预后模式是MCI-AD异质性的又一独立来源,并影响干预性临床试验的主要终点(痴呆转化时间)。
研究设计与样本
- 从三级中心记忆门诊临床数据库选取82例连续MCI-AD患者,基线诊断流程中接受18F-FDG PET并随访至少至临床转化为AD痴呆。
- 全组MCI-AD与年龄匹配健康对照(CTR)在SPM8中比较以验证AD诊断模式,并评估转化时间与脑代谢的相关性以识别预后模式。
- 显著性阈值设为峰值和簇水平p<0.05 FDR校正;每例MCI-AD与CTR行SPM单被试分析,按诊断模式和预后模式有无分组。
- 采用Kaplan-Meier分析评估诊断模式和/或预后模式能否预测痴呆转化速度。
主要发现
- 诊断模式对应典型后部代谢减低(BA 7、18、19、30、31、40),与转化时间不相关。
- 转化时间与右侧颞中回、颞下回及梭状回代谢水平相关(预后模式,BA 20、21、38)。
- Kaplan-Meier分析中,预后模式代谢减低患者较右侧颞中回和颞下回皮层无显著代谢减低者显著更早转化为AD痴呆(9个月 vs 19个月;Log rank p<0.02,Breslow检验p<0.003,Tarone-Ware检验p<0.007)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We aimed to identify the cortical regions where hypometabolism can predict the speed of conversion to dementia in mild cognitive impairment due to Alzheimer's disease (MCI-AD). METHODS: We selected from the clinical database of our tertiary center memory clinic, eighty-two consecutive MCI-AD that underwent 18F-fluorodeoxyglucose (FDG) PET at baseline during the first diagnostic work-up and were followed up at least until their clinical conversion to AD dementia. The whole group of MCI-AD was compared in SPM8 with a group of age-matched healthy controls (CTR) to verify the presence of AD diagnostic-pattern; then the correlation between conversion time and brain metabolism was assessed to identify the prognostic-pattern. Significance threshold was set at p < 0.05 False-Discovery-Rate (FDR) corrected at peak and at cluster level. Each MCI-AD was then compared with CTR by means of a SPM single-subject analysis and grouped according to presence of AD diagnostic-pattern and prognostic-pattern. Kaplan-Meier-analysis was used to evaluate if diagnostic- and/or prognostic-patterns can predict speed of conversion to dementia. RESULTS: Diagnostic-pattern corresponded to typical posterior hypometabolism (BA 7, 18, 19, 30, 31 and 40) and did not correlate with time to conversion, which was instead correlated with metabolic levels in right middle and inferior temporal gyri as well as in the fusiform gyrus (prognostic-pattern, BA 20, 21 and 38). At Kaplan-Meier analysis, patients with hypometabolism in the prognostic pattern converted to AD-dementia significantly earlier than patients not showing significant hypometabolism in the right middle and inferior temporal cortex (9 versus 19 months; Log rank p < 0.02, Breslow test: p < 0.003, Tarone-Ware test: p < 0.007). CONCLUSION: The present findings support the role of FDG PET as a robust progression biomarker even in a naturalist population of MCI-AD. However, not the AD-typical diagnostic-pattern in posterior regions but the middle and inferior temporal metabolism captures speed of conversion to dementia in MCI-AD since baseline. The highlighted prognostic pattern is a further, independent source of heterogeneity in MCI-AD and affects a primary-endpoint on interventional clinical trials (time of conversion to dementia).
引用
- Morbelli S, Bauckneht M, Arnaldi D, et al. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage. Eur J Nucl Med Mol Imaging. 2017. PMID: 28785843. doi:10.1007/s00259-017-3790-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。